documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
6 rows where docket_id = "FDA-2025-E-2426" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2025-E-2426-0006 | FDA | None FDA-2025-E-2426 | Determination of Regulatory Review Period for Purposes of Patent Extension; BLUJEPA | Notice | Determinations | 2026-02-13T05:00:00Z | 2026 | 2 | 2026-02-13T05:00:00Z | 2026-08-13T03:59:59Z | 2026-02-13T20:03:13Z | 2026-02901 | 1 | 0 | 09000064b91aa6fb |
| FDA-2025-E-2426-0005 | FDA | None FDA-2025-E-2426 | Letter to U. S. Patent and Trademark Office | Other | Letter(s) | 2025-11-24T05:00:00Z | 2025 | 11 | 2025-11-24T05:00:00Z | 2025-11-25T02:49:57Z | 0 | 0 | 09000064b909407e | ||
| FDA-2025-E-2426-0004 | FDA | None FDA-2025-E-2426 | Letter from U.S. Patent and Trademark Office to FDA CDER | Other | Letter(s) | 2025-09-22T04:00:00Z | 2025 | 9 | 2025-09-22T04:00:00Z | 2025-09-22T23:26:39Z | 0 | 0 | 09000064b8fd20ee | ||
| FDA-2025-E-2426-0003 | FDA | None FDA-2025-E-2426 | Letter from FDA CDER to U.S. Patent and Trademark Office | Other | Letter(s) | 2025-08-19T04:00:00Z | 2025 | 8 | 2025-08-19T04:00:00Z | 2025-08-20T00:18:38Z | 0 | 0 | 09000064b8f07e2c | ||
| FDA-2025-E-2426-0001 | FDA | None FDA-2025-E-2426 | Letter from U. S. Patent and Trademark Office to FDA CDER | Other | Letter(s) | 2025-07-16T04:00:00Z | 2025 | 7 | 2025-07-16T04:00:00Z | 2025-07-16T22:17:10Z | 0 | 0 | 09000064b8e7b6d6 | ||
| FDA-2025-E-2426-0002 | FDA | None FDA-2025-E-2426 | Patent Extension Application from GlaxoSmithKline (on behalf of Glaxo Group Limited) | Other | Application | 2025-07-16T04:00:00Z | 2025 | 7 | 2025-07-16T04:00:00Z | 2025-07-16T22:17:18Z | 0 | 0 | 09000064b8e7b6d8 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;